Seller record · primepeptides.co

Prime Peptides

Recorded September 2026 · Standard v1.1

Fails 3 of 8 criteria. S1, prescriber requirement: No clinician evaluation is claimed on any of the eight pages read, and every page footer sells the products for research purposes only. 2 more criteria also fail; see the table below.

Research vendor. Passes 5 of 8 criteria. Recorded against Standard v1.1.

A research peptide seller trading from a Santa Barbara address, offering vials of GLP-1 analogues and repair peptides. Its questions page links a certificate page that returns an error, while its testing page carries the certificates it describes.

Operating entity The footer, the contact page, the terms of service and the privacy policy were all read, and none of the four prints a legal entity name.

Dispositions

Code	Criterion	Disposition	Where it was read
S1	Prescriber requirement	FAIL	primepeptides.co/terms-of-service
S2	Prescription gating	FAIL	primepeptides.co/checkout
S3	Pharmacy identification	FAIL	primepeptides.co/about-us
S4	Compounding disclosure	PASS	primepeptides.co/terms-of-service
S5	Analytical documentation	PASS	primepeptides.co/wp-content/uploads/2026/04/Semaglutide-5mg-March-Test-VANGUARD.pdf
S6	Business address	PASS	primepeptides.co/contact
S7	Price disclosure	PASS	primepeptides.co/shop
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

What was read, where, and on what date, for each disposition in the table above.

S1FAILNo clinician evaluation is claimed on any of the eight pages read, and every page footer sells the products for research purposes only.Source: primepeptides.co/terms-of-service.

S2FAILThe order path was walked from the semaglutide page at 70.00 dollars to a checkout collecting billing details, and no screen asked an eligibility question.Source: primepeptides.co/checkout.

S3FAILThe word pharmacy appears on none of the eight pages read, and the seller describes itself as a supplier of research compounds.Source: primepeptides.co/about-us.

S4PASSThe seller offers no compounded drug, and a footer notice on every page read states that the products are for research purposes only and not for human consumption.Source: primepeptides.co/terms-of-service.

S5PASSThe testing page links public certificates with no login, among them one from Vanguard Laboratory of Olympia reporting 99.02 percent purity on semaglutide lot 2122026SM by HPLC with an endotoxin pass. The questions page points instead at a certificate page that returns an error, and that link was followed rather than guessed.Source: primepeptides.co/wp-content/uploads/2026/04/Semaglutide-5mg-March-Test-VANGUARD.pdf.

S6PASSThe contact page prints a street address with a suite number on East De La Guerra Street in Santa Barbara, California.Source: primepeptides.co/contact.

S7PASSThe shop prints 70.00 dollars for semaglutide and 55.00 dollars for BPC-157 with no account required, and the cart carried the same semaglutide figure.Source: primepeptides.co/shop.

S8PASSFDA warning letter 695156, December 2024, names Prime Vitality, Inc. doing business as Prime Peptides and alleges its peptide products are unapproved new drugs. No FDA action has halted the business, and the seller still trades.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: research peptides including semaglutide, tirzepatide and retatrutide, BPC-157, tesamorelin, MOTS-c, GLP-2.

Enforcement documents on file: 1 warning letter

FDA warning letter 695156, issued December 2024, to Prime Vitality, Inc. dba Prime PeptidesThe peptide products offered from primepeptides.co are unapproved new drugs intended for human use, despite research-only labeling.

A warning letter alleges violations and requests a response. It does not halt a business, and it does not remove a seller from this ledger. Every letter recorded here.

Sellers passing S1, prescriber requirement

Records dated September 2026

Records dated August 2026

This seller fails criteria a medical service must meet. The records above belong to sellers that pass S1; some are partner links, disclosed on their records.

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.